e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Idiopathic pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Frequencies and dynamics of peripheral immune cell subsets in idiopathic pulmonary fibrosis: Preliminary results and clinical implications
M. Bocchino, D. Galati, M. De Martino, M. Napolitano, A. Trotta, A. Stanziola, A. Sanduzzi (Naples, Italy)
Source:
Annual Congress 2012 - Idiopathic pulmonary fibrosis
Session:
Idiopathic pulmonary fibrosis
Session type:
Poster Discussion
Number:
3151
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Bocchino, D. Galati, M. De Martino, M. Napolitano, A. Trotta, A. Stanziola, A. Sanduzzi (Naples, Italy). Frequencies and dynamics of peripheral immune cell subsets in idiopathic pulmonary fibrosis: Preliminary results and clinical implications. Eur Respir J 2012; 40: Suppl. 56, 3151
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Levels of CD4CD25 T regulatory cells in bronchial mucosa and peripheral blood of chronic obstructive pulmonary disease indicate involvement of autoimmunity mechanisms
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Analysis of CD4 lymphocyte profiles in sarcoidosis and idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020
Accelerated variant of idiopathic pulmonary fibrosis: clinical and molecular behaviour
Source: Eur Respir J 2007; 30: Suppl. 51, 488s
Year: 2007
The clinical relevance of autoimmunity in idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Differences in alveolar cell populations, natural killer cells and lymphocyte subsets between pulmonary sarcoidosis (PS) and idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2006; 28: Suppl. 50, 745s
Year: 2006
Treg alterations lead to systemic and local immune deregulation in idiopathic pulmonary fibrosis and collagen vascular disease-associated interstitial pneumonia
Source: Annual Congress 2007 - Cell biology of asthma and COPD
Year: 2007
Elucidating the causes and examining the latest clinical findings in pulmonary fibrosis
Source: Eur Respir Rev 2008; 17: 105-107
Year: 2008
Pulmonary eosinophilic syndromes characterization. The role of peripheral eosinophilia as a marker of clinical evolution
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Characterization of peripheral subsets of dendritic cells in COPD patients: preliminary data
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
The role of increasing TIM3 on T cells in patients with nontuberculous mycobacterial lung disease: from immune cell dysfunction to clinical severity
Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease
Year: 2021
Correlation of a progression of fibrotic changes in idiopathic pulmonary fibrosis 1 year after a diagnosis with initial functional and immunologic parameters
Source: Eur Respir J 2004; 24: Suppl. 48, 667s
Year: 2004
Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
Extensive alveoalar lymphocyte apoptosis in pulmonary sarcoidosis (PS) followed by clinical improvement. Two distinct apoptosis presentations?
Source: Eur Respir J 2004; 24: Suppl. 48, 551s
Year: 2004
Evaluation of specific immune complexes in patients with pulmonary sarcoidosis.
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
Alleviation of asthma in a murine model is associated with intrahepatic NKT and CD4 lymphocyte trapping: a potential role for the liver in the immune modulation of asthma
Source: Annual Congress 2008 - Airway cell biology
Year: 2008
Role of neutrophil mechanisms of inflammation in pathogenesis of different types of pulmonary fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 459s
Year: 2003
Circulating endothelial progenitor cells in patients with idiopathic pulmonary fibrosis (preliminary results)
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Immunohistochemical analysis of T lymphocytes (TLs) in lung tissue from patients with idiopathic pulmonary fibrosis (IPF) suggests potential role of CD
8+
TLs in lung injury
Source: Eur Respir J 2004; 24: Suppl. 48, 46s
Year: 2004
Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis
Source: Eur Respir J 2016; 48: 1171-1183
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept